These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 36271004)
1. Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation. Zhai X; Mao C; Shen Q; Zang S; Shen DD; Zhang H; Chen Z; Wang G; Zhang C; Zhang Y; Liu Z Nat Commun; 2022 Oct; 13(1):6276. PubMed ID: 36271004 [TBL] [Abstract][Full Text] [Related]
2. Endogenous ligand recognition and structural transition of a human PTH receptor. Kobayashi K; Kawakami K; Kusakizako T; Miyauchi H; Tomita A; Kobayashi K; Shihoya W; Yamashita K; Nishizawa T; Kato HE; Inoue A; Nureki O Mol Cell; 2022 Sep; 82(18):3468-3483.e5. PubMed ID: 35932760 [TBL] [Abstract][Full Text] [Related]
3. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide. Bhattacharyya S; Pal S; Chattopadhyay N Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739 [TBL] [Abstract][Full Text] [Related]
4. High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist. Ehrenmann J; Schöppe J; Klenk C; Rappas M; Kummer L; Doré AS; Plückthun A Nat Struct Mol Biol; 2018 Dec; 25(12):1086-1092. PubMed ID: 30455434 [TBL] [Abstract][Full Text] [Related]
5. Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTH. Sato T; Verma S; Khatri A; Dean T; Goransson O; Gardella TJ; Wein MN JBMR Plus; 2021 May; 5(5):e10441. PubMed ID: 33977197 [TBL] [Abstract][Full Text] [Related]
6. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation. Vilardaga JP; Lin I; Nissenson RA Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617 [TBL] [Abstract][Full Text] [Related]
7. Molecular insights into peptide agonist engagement with the PTH receptor. Cary BP; Gerrard EJ; Belousoff MJ; Fletcher MM; Jiang Y; Russell IC; Piper SJ; Wootten D; Sexton PM Structure; 2023 Jun; 31(6):668-676.e5. PubMed ID: 37148874 [TBL] [Abstract][Full Text] [Related]
8. Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1. Zhao LH; Yuan QN; Dai AT; He XH; Chen CW; Zhang C; Xu YW; Zhou Y; Wang MW; Yang DH; Xu HE Acta Pharmacol Sin; 2023 Jun; 44(6):1227-1237. PubMed ID: 36482086 [TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways. Cupp ME; Nayak SK; Adem AS; Thomsen WJ J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330 [TBL] [Abstract][Full Text] [Related]
10. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation. Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311 [TBL] [Abstract][Full Text] [Related]
11. Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation. Pioszak AA; Harikumar KG; Parker NR; Miller LJ; Xu HE J Biol Chem; 2010 Apr; 285(16):12435-44. PubMed ID: 20172855 [TBL] [Abstract][Full Text] [Related]
12. Unraveling the Interplay of Extracellular Domain Conformational Changes and Parathyroid Hormone Type 1 Receptor Activation in Class B1 G Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models. Li M; Zhang X; Li S; Guo J ACS Chem Neurosci; 2024 Feb; 15(4):844-853. PubMed ID: 38314550 [TBL] [Abstract][Full Text] [Related]
13. Structure and dynamics of the active human parathyroid hormone receptor-1. Zhao LH; Ma S; Sutkeviciute I; Shen DD; Zhou XE; de Waal PW; Li CY; Kang Y; Clark LJ; Jean-Alphonse FG; White AD; Yang D; Dai A; Cai X; Chen J; Li C; Jiang Y; Watanabe T; Gardella TJ; Melcher K; Wang MW; Vilardaga JP; Xu HE; Zhang Y Science; 2019 Apr; 364(6436):148-153. PubMed ID: 30975883 [TBL] [Abstract][Full Text] [Related]
14. New views into class B GPCRs from the crystal structure of PTH1R. Ehrenmann J; Schöppe J; Klenk C; Plückthun A FEBS J; 2019 Dec; 286(24):4852-4860. PubMed ID: 31670461 [TBL] [Abstract][Full Text] [Related]
15. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation. Yang Y; Wang B Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699 [TBL] [Abstract][Full Text] [Related]
16. Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R. Martin TJ; Sims NA; Seeman E Endocr Rev; 2021 Jul; 42(4):383-406. PubMed ID: 33564837 [TBL] [Abstract][Full Text] [Related]
17. Translating in vitro ligand bias into in vivo efficacy. Luttrell LM; Maudsley S; Gesty-Palmer D Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495 [TBL] [Abstract][Full Text] [Related]
18. Modulation of PTH1R signaling by an ECD binding antibody results in inhibition of β-arrestin 2 coupling. Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B Sci Rep; 2019 Oct; 9(1):14432. PubMed ID: 31594997 [TBL] [Abstract][Full Text] [Related]
19. Proteolytic Cleavage of the Extracellular Domain Affects Signaling of Parathyroid Hormone 1 Receptor. Klenk C; Hommers L; Lohse MJ Front Endocrinol (Lausanne); 2022; 13():839351. PubMed ID: 35273573 [TBL] [Abstract][Full Text] [Related]
20. Functional modulation of PTH1R activation and signaling by RAMP2. Nemec K; Schihada H; Kleinau G; Zabel U; Grushevskyi EO; Scheerer P; Lohse MJ; Maiellaro I Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2122037119. PubMed ID: 35914163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]